{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T12:14:34Z","timestamp":1780056874882,"version":"3.54.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T00:00:00Z","timestamp":1768608000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-15539-1","type":"journal-article","created":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T06:06:20Z","timestamp":1768629980000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The potential of MMP14 as a prognostic and immune biomarker in lung cancer"],"prefix":"10.1186","volume":"26","author":[{"given":"Jiajia","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenpeng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinsheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,17]]},"reference":[{"issue":"6","key":"15539_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"Cancer J Clin"},{"issue":"3","key":"15539_CR2","doi-asserted-by":"publisher","first-page":"975","DOI":"10.21037\/tlcr-24-979","volume":"14","author":"FH Tang","year":"2025","unstructured":"Tang FH, Wong HYT, Tsang PSW, Yau M, Tam SY, Law L, Yau K, Wong J, Farah FHM, Wong J. Recent advancements in lung cancer research: a narrative review. Translational Lung Cancer Res. 2025;14(3):975\u201390.","journal-title":"Translational Lung Cancer Res"},{"issue":"7689","key":"15539_CR3","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature25183","volume":"553","author":"RS Herbst","year":"2018","unstructured":"Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553(7689):446\u201354.","journal-title":"Nature"},{"issue":"10066","key":"15539_CR4","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0140-6736(16)30958-8","volume":"389","author":"FR Hirsch","year":"2017","unstructured":"Hirsch FR, Scagliotti GV, Mulshine JL, Kwon R, Curran WJ Jr., Wu YL, Paz-Ares L. Lung cancer: current therapies and new targeted treatments. Lancet (London England). 2017;389(10066):299\u2013311.","journal-title":"Lancet (London England)"},{"issue":"25","key":"15539_CR5","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1200\/JCO.2017.72.4401","volume":"35","author":"MG Kris","year":"2017","unstructured":"Kris MG, Gaspar LE, Chaft JE, Kennedy EB, Azzoli CG, Ellis PM, Lin SH, Pass HI, Seth R, Shepherd FA, et al. Adjuvant systemic therapy and adjuvant radiation therapy for stage I to IIIA completely resected Non-Small-Cell lung cancers: American society of clinical Oncology\/Cancer care Ontario clinical practice guideline update. J Clin Oncology: Official J Am Soc Clin Oncol. 2017;35(25):2960\u201374.","journal-title":"J Clin Oncology: Official J Am Soc Clin Oncol"},{"issue":"2","key":"15539_CR6","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1111\/cas.14226","volume":"111","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Du H, Li Y, Yuan Y, Chen B, Sun S. Elevated TRIM23 expression predicts cisplatin resistance in lung adenocarcinoma. Cancer Sci. 2020;111(2):637\u201346.","journal-title":"Cancer Sci"},{"issue":"8","key":"15539_CR7","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1001\/jama.2019.11058","volume":"322","author":"KC Arbour","year":"2019","unstructured":"Arbour KC, Riely GJ. Systemic therapy for locally advanced and metastatic Non-Small cell lung cancer: A review. JAMA. 2019;322(8):764\u201374.","journal-title":"JAMA"},{"key":"15539_CR8","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ctrv.2018.04.006","volume":"66","author":"A Leonetti","year":"2018","unstructured":"Leonetti A, Facchinetti F, Rossi G, Minari R, Conti A, Friboulet L, Tiseo M, Planchard D. BRAF in non-small cell lung cancer (NSCLC): pickaxing another brick in the wall. Cancer Treat Rev. 2018;66:82\u201394.","journal-title":"Cancer Treat Rev"},{"issue":"11","key":"15539_CR9","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/j.jtho.2017.08.002","volume":"12","author":"JJ Lin","year":"2017","unstructured":"Lin JJ, Shaw AT. Recent advances in targeting ROS1 in lung cancer. J Thorac Oncology: Official Publication Int Association Study Lung Cancer. 2017;12(11):1611\u201325.","journal-title":"J Thorac Oncology: Official Publication Int Association Study Lung Cancer"},{"key":"15539_CR10","doi-asserted-by":"crossref","unstructured":"Pietrantonio F, Di Nicolantonio F, Schrock AB, Lee J, Tejpar S, Sartore-Bianchi A, et al. ALK, ROS1, and NTRK rearrangements in metastatic colorectal cancer. J Natl Cancer Inst. 2017;109(12):djx089.","DOI":"10.1093\/jnci\/djx089"},{"issue":"10","key":"15539_CR11","first-page":"777","volume":"27","author":"K Zhao","year":"2024","unstructured":"Zhao K, Guo C, Chen Y, Li S. [Advances in the application of adjuvant chemotherapy and targeted therapy in postoperative patients with stage I lung Adenocarcinoma]. Zhongguo Fei Ai Za zhi = Chin J Lung Cancer. 2024;27(10):777\u201384.","journal-title":"Zhongguo Fei Ai Za zhi = Chin J Lung Cancer"},{"issue":"1","key":"15539_CR12","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s13059-018-1501-6","volume":"19","author":"KL Greathouse","year":"2018","unstructured":"Greathouse KL, White JR, Vargas AJ, Bliskovsky VV, Beck JA, von Muhlinen N, Polley EC, Bowman ED, Khan MA, Robles AI, et al. Interaction between the Microbiome and TP53 in human lung cancer. Genome Biol. 2018;19(1):123.","journal-title":"Genome Biol"},{"issue":"7","key":"15539_CR13","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.jtho.2016.04.014","volume":"11","author":"H Yu","year":"2016","unstructured":"Yu H, Boyle TA, Zhou C, Rimm DL, Hirsch FR. PD-L1 expression in lung cancer. J Thorac Oncology: Official Publication Int Association Study Lung Cancer. 2016;11(7):964\u201375.","journal-title":"J Thorac Oncology: Official Publication Int Association Study Lung Cancer"},{"issue":"12","key":"15539_CR14","doi-asserted-by":"publisher","first-page":"3012","DOI":"10.1158\/1078-0432.CCR-16-2554","volume":"23","author":"ZY Dong","year":"2017","unstructured":"Dong ZY, Zhong WZ, Zhang XC, Su J, Xie Z, Liu SY, Tu HY, Chen HJ, Sun YL, Zhou Q, et al. Potential predictive value of TP53 and KRAS mutation status for response to PD-1 Blockade immunotherapy in lung adenocarcinoma. Clin Cancer Research: Official J Am Association Cancer Res. 2017;23(12):3012\u201324.","journal-title":"Clin Cancer Research: Official J Am Association Cancer Res"},{"issue":"32","key":"15539_CR15","doi-asserted-by":"publisher","first-page":"eadn9519","DOI":"10.1126\/sciadv.adn9519","volume":"10","author":"H Wang","year":"2024","unstructured":"Wang H, Feng J, Fu Z, Xu T, Liu J, Yang S, Li Y, Deng J, Zhang Y, Guo M, et al. Epitranscriptomic m(5)C methylation of SARS-CoV-2 RNA regulates viral replication and the virulence of progeny viruses in the new infection. Sci Adv. 2024;10(32):eadn9519.","journal-title":"Sci Adv"},{"issue":"6","key":"15539_CR16","doi-asserted-by":"publisher","first-page":"e23749","DOI":"10.1002\/jbt.23749","volume":"38","author":"Y Cui","year":"2024","unstructured":"Cui Y, Lv P, Zhang C. NSUN6 mediates 5-methylcytosine modification of METTL3 and promotes colon adenocarcinoma progression. J Biochem Mol Toxicol. 2024;38(6):e23749.","journal-title":"J Biochem Mol Toxicol"},{"issue":"1","key":"15539_CR17","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41419-025-07414-5","volume":"16","author":"Q Qi","year":"2025","unstructured":"Qi Q, Zhong R, Huang Y, Tang Y, Zhang XW, Liu C, Gao CF, Zhou L, Yu J, Wu LY. The RNA M5C methyltransferase NSUN2 promotes progression of hepatocellular carcinoma by enhancing PKM2-mediated Glycolysis. Cell Death Dis. 2025;16(1):82.","journal-title":"Cell Death Dis"},{"issue":"1","key":"15539_CR18","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12943-023-01780-4","volume":"22","author":"Y Wang","year":"2023","unstructured":"Wang Y, Wei J, Feng L, Li O, Huang L, Zhou S, Xu Y, An K, Zhang Y, Chen R, et al. Aberrant m5C hypermethylation mediates intrinsic resistance to gefitinib through NSUN2\/YBX1\/QSOX1 axis in EGFR-mutant non-small-cell lung cancer. Mol Cancer. 2023;22(1):81.","journal-title":"Mol Cancer"},{"issue":"1","key":"15539_CR19","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1038\/s41467-024-45558-8","volume":"15","author":"EM Wenzel","year":"2024","unstructured":"Wenzel EM, Pedersen NM, Elfmark LA, Wang L, Kjos I, Stang E, Maler\u00f8d L, Brech A, Stenmark H, Raiborg C. Intercellular transfer of cancer cell invasiveness via endosome-mediated protease shedding. Nat Commun. 2024;15(1):1277.","journal-title":"Nat Commun"},{"key":"15539_CR20","doi-asserted-by":"crossref","unstructured":"Niland S, Riscanevo AX, Eble JA. Matrix metalloproteinases shape the tumor microenvironment in cancer progression. Int J Mol Sci. 2021;23(1):146","DOI":"10.3390\/ijms23010146"},{"issue":"7","key":"15539_CR21","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.cell.2022.02.012","volume":"185","author":"RD Mazor","year":"2022","unstructured":"Mazor RD, Nathan N, Gilboa A, Stoler-Barak L, Moss L, Solomonov I, Hanuna A, Divinsky Y, Shmueli MD, Hezroni H, et al. Tumor-reactive antibodies evolve from non-binding and autoreactive precursors. Cell. 2022;185(7):1208\u2013e12221221.","journal-title":"Cell"},{"issue":"2","key":"15539_CR22","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s12013-014-9974-8","volume":"70","author":"H Wang","year":"2014","unstructured":"Wang H, Zhang X, Huang L, Li J, Qu S, Pan F. Matrix metalloproteinase-14 expression and its prognostic value in cervical carcinoma. Cell Biochem Biophys. 2014;70(2):729\u201334.","journal-title":"Cell Biochem Biophys"},{"issue":"1","key":"15539_CR23","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13048-021-00852-7","volume":"14","author":"MC Vos","year":"2021","unstructured":"Vos MC, van der Wurff AAM, van Kuppevelt TH, Massuger L. The role of MMP-14 in ovarian cancer: a systematic review. J Ovarian Res. 2021;14(1):101.","journal-title":"J Ovarian Res"},{"key":"15539_CR24","doi-asserted-by":"publisher","first-page":"102420","DOI":"10.1016\/j.pdpdt.2021.102420","volume":"35","author":"S Ogawa","year":"2021","unstructured":"Ogawa S, Kubo H, Murayama Y, Kubota T, Yubakami M, Matsumoto T, Ohashi T, Okamoto K, Kuriki Y, Hanaoka K, et al. Matrix metalloprotease-14 is a target enzyme for detecting peritoneal metastasis in gastric cancer. Photodiagn Photodyn Ther. 2021;35:102420.","journal-title":"Photodiagn Photodyn Ther"},{"issue":"8","key":"15539_CR25","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.neo.2021.06.001","volume":"23","author":"S Ozaki","year":"2021","unstructured":"Ozaki S, Umakoshi A, Yano H, Ohsumi S, Sumida Y, Hayase E, Usa E, Islam A, Choudhury ME, Nishi Y, et al. Chloride intracellular channel protein 2 is secreted and inhibits MMP14 activity, while preventing tumor cell invasion and metastasis. Neoplasia (New York NY). 2021;23(8):754\u201365.","journal-title":"Neoplasia (New York NY)"},{"key":"15539_CR26","doi-asserted-by":"crossref","unstructured":"Sun W, Zhang Y, Liu B, Duan Y, Li W, Chen J. Gene polymorphism of MUC15, MMP14, BRAF, and COL1A1 Is associated with capsule formation in hepatocellular carcinoma. Can J Gastroenterol Hepatol. 2021;2021:9990305.","DOI":"10.1155\/2021\/9990305"},{"key":"15539_CR27","doi-asserted-by":"crossref","unstructured":"Altadill A, Eiro N, Gonz\u00e1lez LO, Andicoechea A, Fern\u00e1ndez-Francos S, Rodrigo L, et al. Relationship between metalloprotease-7 and \u2013\u200914 and tissue inhibitor of metalloprotease 1 expression by mucosal stromal cells and colorectal cancer development in inflammatory bowel disease. Biomed. 2021;9(5):495.","DOI":"10.3390\/biomedicines9050495"},{"key":"15539_CR28","doi-asserted-by":"crossref","unstructured":"Pach E, Brinckmann J, R\u00fcbsam M, K\u00fcmper M, Mauch C, Zigrino P. Fibroblast MMP14-dependent collagen processing is necessary for melanoma growth. Cancers. 2021;13(8):1984.","DOI":"10.3390\/cancers13081984"},{"key":"15539_CR29","doi-asserted-by":"crossref","unstructured":"Lee HS, Kim WJ. The role of matrix metalloproteinase in inflammation with a focus on infectious diseases. Int J Mol Sci. 2022;23(18):10546.","DOI":"10.3390\/ijms231810546"},{"key":"15539_CR30","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.matbio.2015.01.019","volume":"44\u201346","author":"G Shay","year":"2015","unstructured":"Shay G, Lynch CC, Fingleton B. Moving targets: emerging roles for MMPs in cancer progression and metastasis. Matrix Biology: J Int Soc Matrix Biology. 2015;44\u201346:200\u20136.","journal-title":"Matrix Biology: J Int Soc Matrix Biology"},{"issue":"3","key":"15539_CR31","doi-asserted-by":"publisher","first-page":"e3000202","DOI":"10.1371\/journal.pbio.3000202","volume":"17","author":"M Postma","year":"2019","unstructured":"Postma M, Goedhart J. PlotsOfData-A web app for visualizing data together with their summaries. PLoS Biol. 2019;17(3):e3000202.","journal-title":"PLoS Biol"},{"issue":"7532","key":"15539_CR32","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/517109a","volume":"517","author":"S Tippmann","year":"2015","unstructured":"Tippmann S. Programming tools: adventures with R. Nature. 2015;517(7532):109\u201310.","journal-title":"Nature"},{"issue":"2","key":"15539_CR33","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","volume":"173","author":"J Liu","year":"2018","unstructured":"Liu J, Lichtenberg T, Hoadley KA, Poisson LM, Lazar AJ, Cherniack AD, Kovatich AJ, Benz CC, Levine DA, Lee AV, et al. An integrated TCGA Pan-Cancer clinical data resource to drive High-Quality survival outcome analytics. Cell. 2018;173(2):400\u2013e416411.","journal-title":"Cell"},{"key":"15539_CR34","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, M\u00fcller M. pROC: an open-source package for R and S\u2009+\u2009to analyze and compare ROC curves. BMC Bioinformatics. 2011;12:77.","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"15539_CR35","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, et al. Gene ontology: tool for the unification of biology. The gene ontology consortium. Nat Genet. 2000;25(1):25\u20139.","journal-title":"Nat Genet"},{"issue":"1","key":"15539_CR36","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28(1):27\u201330.","journal-title":"Nucleic Acids Res"},{"issue":"43","key":"15539_CR37","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102(43):15545\u201350.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"15539_CR38","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","volume":"19","author":"DS Chandrashekar","year":"2017","unstructured":"Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi B, Varambally S. UALCAN: A portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia (New York NY). 2017;19(8):649\u201358.","journal-title":"Neoplasia (New York NY)"},{"key":"15539_CR39","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-4939-7493-1_12","volume":"1711","author":"B Chen","year":"2018","unstructured":"Chen B, Khodadoust MS, Liu CL, Newman AM, Alizadeh AA. Profiling tumor infiltrating immune cells with CIBERSORT. Methods Mol Biology (Clifton NJ). 2018;1711:243\u201359.","journal-title":"Methods Mol Biology (Clifton NJ)"},{"key":"15539_CR40","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Mart\u00ednez E, Vegesna R, Kim H, Torres-Garcia W, Trevi\u00f1o V, Shen H, Laird PW, Levine DA, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612.","journal-title":"Nat Commun"},{"key":"15539_CR41","doi-asserted-by":"publisher","first-page":"5599","DOI":"10.2147\/CMAR.S318704","volume":"13","author":"Y Fang","year":"2021","unstructured":"Fang Y, Huang S, Han L, Wang S, Xiong B. Comprehensive analysis of peritoneal metastasis sequencing data to identify LINC00924 as a prognostic biomarker in gastric cancer. Cancer Manage Res. 2021;13:5599\u2013611.","journal-title":"Cancer Manage Res"},{"issue":"6","key":"15539_CR42","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41568-020-0253-2","volume":"20","author":"I Barbieri","year":"2020","unstructured":"Barbieri I, Kouzarides T. Role of RNA modifications in cancer. Nat Rev Cancer. 2020;20(6):303\u201322.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"15539_CR43","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1038\/s41467-021-22024-3","volume":"12","author":"L Garcia-Martinez","year":"2021","unstructured":"Garcia-Martinez L, Zhang Y, Nakata Y, Chan HL, Morey L. Epigenetic mechanisms in breast cancer therapy and resistance. Nat Commun. 2021;12(1):1786.","journal-title":"Nat Commun"},{"issue":"12","key":"15539_CR44","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s13238-021-00846-7","volume":"13","author":"L Sun","year":"2022","unstructured":"Sun L, Zhang H, Gao P. Metabolic reprogramming and epigenetic modifications on the path to cancer. Protein Cell. 2022;13(12):877\u2013919.","journal-title":"Protein Cell"},{"issue":"1","key":"15539_CR45","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12943-024-02041-8","volume":"23","author":"Y Li","year":"2024","unstructured":"Li Y, Jin H, Li Q, Shi L, Mao Y, Zhao L. The role of RNA methylation in tumor immunity and its potential in immunotherapy. Mol Cancer. 2024;23(1):130.","journal-title":"Mol Cancer"},{"issue":"41","key":"15539_CR46","doi-asserted-by":"publisher","first-page":"71024","DOI":"10.18632\/oncotarget.20297","volume":"8","author":"Y Xiong","year":"2017","unstructured":"Xiong Y, Zhang J, Shi L, Ning Y, Zhu Y, Chen S, Yang M, Chen J, Zhou GW, Li Q. NOGO-B promotes EMT in lung fibrosis via MMP14 mediates free TGF-beta1 formation. Oncotarget. 2017;8(41):71024\u201337.","journal-title":"Oncotarget"},{"issue":"1","key":"15539_CR47","doi-asserted-by":"publisher","first-page":"150","DOI":"10.2337\/db07-0903","volume":"57","author":"U Hiden","year":"2008","unstructured":"Hiden U, Glitzner E, Ivanisevic M, Djelmis J, Wadsack C, Lang U, Desoye G. MT1-MMP expression in first-trimester placental tissue is upregulated in type 1 diabetes as a result of elevated insulin and tumor necrosis factor-alpha levels. Diabetes. 2008;57(1):150\u20137.","journal-title":"Diabetes"},{"issue":"2","key":"15539_CR48","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.bone.2004.10.010","volume":"36","author":"W Lehmann","year":"2005","unstructured":"Lehmann W, Edgar CM, Wang K, Cho TJ, Barnes GL, Kakar S, Graves DT, Rueger JM, Gerstenfeld LC, Einhorn TA. Tumor necrosis factor alpha (TNF-alpha) coordinately regulates the expression of specific matrix metalloproteinases (MMPS) and angiogenic factors during fracture healing. Bone. 2005;36(2):300\u201310.","journal-title":"Bone"},{"issue":"4","key":"15539_CR49","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1002\/bit.22310","volume":"103","author":"KA Wieghaus","year":"2009","unstructured":"Wieghaus KA, Gianchandani EP, Neal RA, Paige MA, Brown ML, Papin JA, Botchwey EA. Phthalimide neovascular factor 1 (PNF1) modulates MT1-MMP activity in human microvascular endothelial cells. Biotechnol Bioeng. 2009;103(4):796\u2013807.","journal-title":"Biotechnol Bioeng"},{"issue":"12","key":"15539_CR50","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1038\/s43018-024-00858-2","volume":"5","author":"J Zhao","year":"2024","unstructured":"Zhao J, Zeng R, Li X, Lu Y, Wang Z, Peng H, Chen H, Fu M, Zhang Y, Huang Y, et al. Dura immunity configures leptomeningeal metastasis immunosuppression for cerebrospinal fluid barrier invasion. Nat Cancer. 2024;5(12):1940\u201361.","journal-title":"Nat Cancer"},{"issue":"2","key":"15539_CR51","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1158\/0008-5472.CAN-11-2647","volume":"72","author":"JL Johnson","year":"2012","unstructured":"Johnson JL, Pillai S, Pernazza D, Sebti SM, Lawrence NJ, Chellappan SP. Regulation of matrix metalloproteinase genes by E2F transcription factors: Rb-Raf-1 interaction as a novel target for metastatic disease. Cancer Res. 2012;72(2):516\u201326.","journal-title":"Cancer Res"},{"key":"15539_CR52","doi-asserted-by":"crossref","unstructured":"Lorente JS, Sokolov AV, Ferguson G, Schi\u00f6th HB, Hauser AS, Gloriam DE. GPCR drug discovery: new agents, targets and indications. Nat Rev Drug Discovery. 2025;24(6):458\u201379.","DOI":"10.1038\/s41573-025-01139-y"},{"key":"15539_CR53","doi-asserted-by":"publisher","first-page":"107070","DOI":"10.1016\/j.phrs.2024.107070","volume":"200","author":"D Peng","year":"2024","unstructured":"Peng D, Li J, Li Y, Bai L, Xiong A, He X, Li X, Ran Q, Zhang L, Jiang M, et al. MMP14(high) macrophages orchestrate progressive pulmonary fibrosis in SR-Ag-induced hypersensitivity pneumonitis. Pharmacol Res. 2024;200:107070.","journal-title":"Pharmacol Res"},{"issue":"1","key":"15539_CR54","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13045-024-01581-2","volume":"17","author":"W Cheng","year":"2024","unstructured":"Cheng W, Kang K, Zhao A, Wu Y. Dual Blockade immunotherapy targeting PD-1\/PD-L1 and CTLA-4 in lung cancer. J Hematol Oncol. 2024;17(1):54.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"15539_CR55","doi-asserted-by":"publisher","first-page":"100889","DOI":"10.1016\/j.tranon.2020.100889","volume":"14","author":"W Huang","year":"2021","unstructured":"Huang W, Chen JJ, Xing R, Zeng YC. Combination therapy: future directions of immunotherapy in small cell lung cancer. Translational Oncol. 2021;14(1):100889.","journal-title":"Translational Oncol"},{"issue":"5","key":"15539_CR56","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s10142-024-01447-3","volume":"24","author":"J Wang","year":"2024","unstructured":"Wang J, Zheng C, Lu J, Xu X, Xiang G, Li J, Zhang J, Mu X, Lu Q. The mechanism of MMP14-positive tumor-associated fibroblast subsets in inhibiting PD-1 immunotherapy for esophageal cancer through Exosomal tsRNA-10522. Funct Integr Genom. 2024;24(5):186.","journal-title":"Funct Integr Genom"},{"issue":"8","key":"15539_CR57","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1002\/mc.23551","volume":"62","author":"RM Peter","year":"2023","unstructured":"Peter RM, Sarwar MS, Mostafa SZ, Wang Y, Su X, Kong AN. Histone deacetylase inhibitor Belinostat regulates metabolic reprogramming in killing KRAS-mutant human lung cancer cells. Mol Carcinog. 2023;62(8):1136\u201346.","journal-title":"Mol Carcinog"},{"issue":"6","key":"15539_CR58","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1001\/jamaoncol.2020.0409","volume":"6","author":"O Arrieta","year":"2020","unstructured":"Arrieta O, Barr\u00f3n F, Ram\u00edrez-Tirado LA, Zatarain-Barr\u00f3n ZL, Cardona AF, D\u00edaz-Garc\u00eda D, Yamamoto Ramos M, Mota-Vega B, Carmona A, Peralta \u00c1lvarez MP, et al. Efficacy and safety of pembrolizumab plus docetaxel vs docetaxel alone in patients with previously treated advanced Non-Small cell lung cancer: the PROLUNG phase 2 randomized clinical trial. JAMA Oncol. 2020;6(6):856\u201364.","journal-title":"JAMA Oncol"},{"issue":"1","key":"15539_CR59","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12943-024-01991-3","volume":"23","author":"A Puyalto","year":"2024","unstructured":"Puyalto A, Rodr\u00edguez-Rem\u00edrez M, L\u00f3pez I, Macaya I, Guruceaga E, Olmedo M, Vilalta-Lacarra A, Welch C, Sandiego S, Vicent S, et al. Trametinib sensitizes KRAS-mutant lung adenocarcinoma tumors to PD-1\/PD-L1 axis Blockade via Id1 downregulation. Mol Cancer. 2024;23(1):78.","journal-title":"Mol Cancer"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-15539-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15539-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15539-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T16:06:29Z","timestamp":1771430789000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-025-15539-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,17]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15539"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-15539-1","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,17]]},"assertion":[{"value":"5 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This study did not involve human or animal experiments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"256"}}